C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study

Background: Biomarkers for predicting response to immune checkpoint inhibitors (ICI) are scarce and often lack external validation. This study provides a comprehensive investigation of pretreatment C-reactive protein (CRP) levels as well as its longitudinal trajectories as a marker of treatment resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Riedl, Jakob M., Barth, Dominik A., Brueckl, Wolfgang M., Zeitler, Gloria, Foris, Vasile, Mollnar, Stefanie, Stotz, Michael, Rossmann, Christopher H., Terbuch, Angelika, Balic, Marija, Niedrist, Tobias, Bertsch, Thomas, Stoeger, Herbert, Pichler, Martin, Olschewski, Horst, Absenger, Gudrun, Ficker, Joachim H., Gerger, Armin, Posch, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464328/
https://www.ncbi.nlm.nih.gov/pubmed/32824580
http://dx.doi.org/10.3390/cancers12082319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464328/
https://www.ncbi.nlm.nih.gov/pubmed/32824580
http://dx.doi.org/10.3390/cancers12082319

Ejemplares similares